Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder

被引:87
|
作者
van Dyck, CH
Quinlan, DM
Cretella, LM
Staley, JK
Malison, RT
Baldwin, RM
Seibyl, JP
Innis, RB
机构
[1] Yale Univ, Sch Med, Dept Psychiat, Cognit Disorders Clin, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA
[3] W Haven Vet Affairs Med Ctr, West Haven, CT USA
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2002年 / 159卷 / 02期
关键词
D O I
10.1176/appi.ajp.159.2.309
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The authors examined whether patients with attention deficit hyperactivity disorder (ADHD) have altered striataldopamine transporter levels, which may explain psychostimulant effects in this disorder. Method: Single photon emission computed tomography and [I-123]2beta-carbomethoxy-3beta-(4-iodophenyl)tropane ([I-123]beta-CIT) were used to assess dopamine transporter availability in nine adult patients with ADHD (eight of whom were stimulant naive) and nine age- and gender-matched healthy comparison subjects. Results: Striatal [I-123]beta-CIT binding did not differ significantly between the ADHD and comparison subjects. Conclusions: The findings suggest that a hypothesized dysregulation of dopamine function in ADHD does not entail altered dopamine transporter levels.
引用
收藏
页码:309 / 312
页数:4
相关论文
共 50 条
  • [31] Adult attention deficit hyperactivity disorder.
    Faraone S.V.
    Tsuang M.T.
    Current Psychiatry Reports, 2001, 3 (2) : 129 - 130
  • [32] Trauma and adult attention deficit hyperactivity disorder
    Kaya, A.
    Taner, Y.
    Guclu, B.
    Taner, E.
    Kaya, Y.
    Bahcivan, H. G.
    Benli, I. T.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (01) : 9 - 16
  • [33] Adult Attention Deficit Hyperactivity Disorder and comorbidity
    Rosca-Rebaudengo, P
    Durst, R
    Dickman, M
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2000, 4 (01) : 35 - 39
  • [34] Schizotypy, attention deficit hyperactivity disorder, and dopamine genes
    Ettinger, Ulrich
    Joober, Ridha
    De Guzman, Rosherrie
    O'Driscoll, Gillian A.
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (06) : 764 - 767
  • [35] Dopamine activity in adolescents with attention deficit hyperactivity disorder
    Gjedde, A.
    NORDIC JOURNAL OF PSYCHIATRY, 2006, 60 (04) : 324 - 324
  • [36] Endophenotypes of attention deficit hyperactivity disorder and the dopamine system
    Maher, BS
    Ferrell, RE
    Devlin, B
    Kirillova, GP
    Tarter, RE
    Vanyukov, MM
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 14 - 14
  • [37] Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan
    Shang, Chi-Yung
    Gau, Susan Shur-Fen
    Liu, Chih-Min
    Hwu, Hai-Gwo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 421 - 428
  • [38] Effects of the dopamine transporter gene on neuroimaging findings in different attention deficit hyperactivity disorder presentations
    Bacanli, Ali
    Unsel-Bolat, Gul
    Suren, Serkan
    Yazici, Kemal Utku
    Calli, Cem
    Jafari, Duygu Aygunes
    Kosova, Buket
    Rohde, Luis Augusto
    Ercan, Eyup Sabri
    BRAIN IMAGING AND BEHAVIOR, 2021, 15 (02) : 1103 - 1114
  • [39] Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples
    S Curran
    J Mill
    E Tahir
    L Kent
    S Richards
    A Gould
    L Huckett
    J Sharp
    C Batten
    S Fernando
    F Ozbay
    Y Yazgan
    E Simonoff
    M Thompson
    E Taylor
    P Asherson
    Molecular Psychiatry, 2001, 6 : 425 - 428
  • [40] Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples
    Curran, S
    Mill, J
    Tahir, E
    Kent, L
    Richards, S
    Gould, A
    Huckett, L
    Sharp, J
    Batten, C
    Fernando, S
    Ozbay, F
    Yazgan, Y
    Simonoff, E
    Thompson, M
    Taylor, E
    Asherson, P
    MOLECULAR PSYCHIATRY, 2001, 6 (04) : 425 - 428